Sansure Biotech Inc.
SHH: 688289.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Lizhong Dai
- Employees
- 2,006
- Headquarters
- Changsha, China
- IPO year
- 2020
- Market cap
- CN¥10.4B
- Website
- https://www.sansure.com.cn
Loading 688289…
Loading profile data…Frequently asked questions about 688289
What does Sansure Biotech Inc. (688289.SS) do?
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits fo...
Where does 688289.SS trade?
Sansure Biotech Inc. (688289.SS) trades on the Shanghai Stock Exchange.
What sector is 688289.SS in?
Sansure Biotech Inc. (688289.SS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Sansure Biotech Inc.?
Lizhong Dai is the chief executive officer of Sansure Biotech Inc. (688289.SS).
Where is Sansure Biotech Inc. headquartered?
Sansure Biotech Inc. is headquartered in China.
Does 688289.SS pay a dividend?
Yes — Sansure Biotech Inc. (688289.SS) paid a trailing twelve-month dividend of CNY 0.54 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688289.SS go public?
Sansure Biotech Inc. (688289.SS) completed its initial public offering in 2020.